These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Some iatrogenic ocular diseases from systemically administered drugs. Bernstein HN Int Ophthalmol Clin; 1970; 10(3):553-619. PubMed ID: 4933547 [No Abstract] [Full Text] [Related]
3. Chloroquine and organic changes in the eye. Carr RE Dis Nerv Syst; 1968 Mar; 29(3):Suppl:36-9. PubMed ID: 5672562 [No Abstract] [Full Text] [Related]
4. Drug-induced macular disease. Potts AM Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(6):1054-7. PubMed ID: 5971468 [No Abstract] [Full Text] [Related]
5. The ocular toxicity of chloroquine. Percival SP Trans Ophthalmol Soc U K (1962); 1967; 87():355-7. PubMed ID: 5255230 [No Abstract] [Full Text] [Related]
6. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers. Rubin M Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735 [No Abstract] [Full Text] [Related]
7. Electrodiagnosis in drug-induced disorders of the eye. Adlakha D; Crews SJ; Shearer AC; Tonks EL Trans Ophthalmol Soc U K (1962); 1967; 87():267-84. PubMed ID: 5255222 [No Abstract] [Full Text] [Related]
9. Some aspects of retinal drug toxicity. Crews SJ Ophthalmologica; 1969; 1-3(1):232-44. PubMed ID: 5810709 [No Abstract] [Full Text] [Related]
10. Acute toxic effects of chloroquine on the cat retina: ultrastructural changes. Smith RS; Berson EL Invest Ophthalmol; 1971 Apr; 10(4):237-46. PubMed ID: 4323627 [No Abstract] [Full Text] [Related]
11. [On the problem of chloroquine damage to the eye]. Böke W; Bäumer A; Müller-Limmroth W; Mludek M Klin Monbl Augenheilkd; 1967 Nov; 151(5):617-33. PubMed ID: 5597423 [No Abstract] [Full Text] [Related]
12. [Ocular involvement in chloroquine therapy]. Godel V; Nemet P; Stein R Harefuah; 1972 Jul; 83(2):60-3. PubMed ID: 5068910 [No Abstract] [Full Text] [Related]
13. [Electroretinographic and electroencephalographic studies in Stargardt's disease]. François J; De Rouck A Klin Monbl Augenheilkd; 1965 Dec; 147(5):654-62. PubMed ID: 5869305 [No Abstract] [Full Text] [Related]
14. Pigmentation and retinopathy due to chloroquine. Stewart TW; Miles DW; Earnshaw ER Acta Derm Venereol; 1968; 48(1):47-52. PubMed ID: 4174103 [No Abstract] [Full Text] [Related]
15. Ocular side effects of indomethacin. Palimeris G; Koliopoulos J; Velissaropoulos P Ophthalmologica; 1972; 164(5):339-53. PubMed ID: 4537509 [No Abstract] [Full Text] [Related]
16. Ocular toxicity of antimalarial drugs. Long-term follow-up. Carr RE; Henkind P; Rothfield N; Siegel IM Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592 [No Abstract] [Full Text] [Related]
17. The prevention of drug-induced retinopathies. Crews SJ Trans Ophthalmol Soc U K (1962); 1966; 86():63-76. PubMed ID: 5335103 [No Abstract] [Full Text] [Related]
18. Chloroquine toxicity in the human eye. Histopathologic observations by electron microscopy. Ramsey MS; Fine BS Am J Ophthalmol; 1972 Feb; 73(2):229-35. PubMed ID: 4335678 [No Abstract] [Full Text] [Related]
19. [Undesirable adverse effects of the antirheumatic pharmacotherapy on the eyes]. Verraz R Arch Sci Med (Torino); 1974; 131(3):167-72. PubMed ID: 4463933 [No Abstract] [Full Text] [Related]
20. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy. Bernstein HN Am J Med; 1983 Jul; 75(1A):25-34. PubMed ID: 6869408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]